
Haim-Moshe AdahanTel Aviv University | TAU · Pain Rehabilitaiton
Haim-Moshe Adahan
About
25
Publications
17,759
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
282
Citations
Citations since 2017
Introduction
1996-97 invented his first original Interventional Pain management technique; namely, a new technique for relieving shoulders pain involving an original approach for Supra-scapular nerve blocks.
2009-present: Working alongside Professor Marshal Devor, Dr. Adahan challenged conventional thinking as to the cause of Phantom limb pains .http://www.bodyinmind.org/phantom-limb-pain-drg )
2014-present- development of his 2nd original Interventional Pain management technique . It involves injecting Botulin toxin to the hard to reach Subscapular muscle for the relief of Tight spastic Painful hemiplegic Shoulders under fluoroscopic guidance.
2000-2015- accumulation of clinical experience treating over 2000 patients with intractable neuropathic pain with medical cannabis.
Publications
Publications (25)
Background:
Although studied in a few randomized controlled trials, the efficacy of medical cannabis (MC) for chronic pain remains controversial. Using an alternative approach, this multicentre, questionnaire-based prospective cohort was aimed to assess the long-term effects of MC on chronic pain of various aetiologies and to identify predictors f...
Introduction:
What is a physician to do when the tools in his toolbox fail him? In the field of chronic pain, we are told that imaging studies are often so non-specific as to barely distinguish between symptomatic and asymptomatic individuals. "Advanced pain management techniques and off-label use of popular pain medicines do not withstand the rig...
Background and aims: Although the use of Herbal Cannabis (HC) for chronic pain is rising, scientific evidence for its associations with reduction in analgesics reduction is scarce. The aim of this study is to present the changes from baseline in analgesics consumption during one year of HC treatment.
Methods: Patients with chronic pain for whom an...
Introduction
The use of medical cannabis (MC) for chronic pain is rising in many parts of the world. In Israel, approximately 32,000 patients are currently licensed to use of medical cannabis, mostly for the relief of chronic pain and 2,000 new licenses are expected to be issued yearly. Although some prospective cohorts on the effectiveness and saf...
Introduction
The use of medical cannabis (MC) for chronic pain is rising in many parts of the world. In Israel, approximately 32,000 patients are currently licensed to use of medical cannabis, mostly for the relief of chronic pain and 2,000 new licenses are expected to be issued yearly. Although some prospective cohorts on the effectiveness and saf...
Background: Although the use of medical cannabis (MC) for chronic pain is rising, scientific evidence on its long-term effectiveness and safety is scarce.
Study Aims: The aim of this study was to set up a patient registry on the treatment of MC for the relief of chronic pain in Israel, by prospectively collecting data on the effectiveness and safet...
The aim of this study was to set up a patient registry on the treatment of MC for the relief of chronic pain in Israel. By prospectively collecting data on the effectiveness and safety of MC.
Current results from the findings of the Israeli medical cannabis registry for chronic pain treatment: effectiveness and safety measures.
Introduction Although the use of medical cannabis (MC) for chronic pain is rising, scientific evidence on its long-term effectiveness and safety is scarce. The aim of the study is to set up a patient registry on the treatment of MC for the relief of chronic pain in Israel. By prospectively collecting data on the effectiveness and safety of MC,...
A Multi-Center Registry of Medical Cannabis (MC) for Chronic Pain: Initial Results
Joshua Aviram, RN, PhC1,2, Dorit Pud, PhD1, Elon Eisenberg, MD3,4
1Faculty of Social Welfare and Health Sciences, University of Haifa, Israel; 2Internal Ward C, Rambam Medical Center, Haifa, Israel; 3Institute of Pain Medicine, Rambam Medical Center, Haifa, Israel;...
Introduction: Although the use of Medical cannabis (MC) for chronic pain is rising, scientific evidence for its long-term efficacy is scarce.
Aims: A multi-center registry aimed to prospectively collect data on the effectiveness and safety of MC and to identify predictors for success\failure of MC treatment was structured in late 2015. This is an i...
Perliminary results of the base-line time point Characteristics
A Multi-Center Registry of Medical Cannabis (MC) for Chronic Pain: Initial Results
Joshua Aviram1,2, Dorit Pud1, Miriam Oginitz3, Bareket Schiff-Keren4, Tamar Yashar5, Haim-Moshe Adahan6, Silviu Brill7, Itai Gur-Arie8, and Elon Eisenberg3,9.
1Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel; 2Rambam Health Care Cam...
Conclusions 1. HR was a more popular choice among patients. 2. Patients choosing HR reported greater amelioration than those choosing AMT. 3. Patients choosing HR were found to have greater treatment compliance. 4. HR practiced by a neurologist is feasible in a standard neurological outpatient clinic. Diagnosis and Treatment choice: hypnosis vs. Am...
Peripheral nervous system origin of phantom limb pain
Apostol Vaso a, Haim-Moshe Adahan b, Artan Gjika a, Skerdi Zahaj a, Tefik Zhurda a, Gentian Vyshka c,
Marshall Devor d,⇑
a Pain and Rehabilitation Clinic, National Trauma Center, Trauma University Hospital and Galenus Clinic, Tirana, Albania
b Pain Rehabilitation Unit, Chaim Sheba Medical Center...
Nearly all amputees continue to feel their missing limb as if it still existed, and many experience chronic phantom limb pain (PLP). There is currently a broad consensus among investigators that the origin of these sensations is a top-down phenomenon, triggered by loss of sensory input and caused by maladaptive cortical plasticity. We tested the al...
Background / Purpose:
Here we report the results of treatment with a novel surface acoustic wave ultrasound treatment device, The Nanovibronix Painshield, in 25 subjects with trigeminal neuralgia.
Main conclusion:
17 out of 21 responding patients treated (81%) achieved a final Barrow Neurological Index score of IIIB or less after an average of...
Although both pharmacological and behavioral interventions may relieve tension-type headache, data are lacking regarding treatment preference, long-term patient compliance, and feasibility of behavioral intervention in a standard neurological outpatient clinic setting.
To describe patient choice, long-term compliance, and clinical outcome in a neur...